Because patients treated with GLP-1 RAs are more likely to retain gastric contents (RGC), the risk of aspiration may persist even when standard preoperative fasting guidelines are followed
These professionals must be aware of which medications necessitate prior authorization to prevent delays in treatment
The GLP-1 story is one were watching closely because it validates what our clinical team has long understood: the body and mind dont operate in separate silos
Alczar, R
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
The reason why we take them topically, orally, or via injection is to influence our body into doing things it already does but better, faster, slower, etc